Trials / Recruiting
RecruitingNCT07529847
Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Foundation University Islamabad · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Detailed description
Bronchial asthma is a chronic inflammatory airway disease in which there are recurrent episodes shortness of breath, wheezing,and limitation in airflow. Chronic hyperventilation and dysfunctional breathing pattern and commonly contribute to symptom severity and poor asthma control.This study aims to compare the effects of Alternate Nostril Breathing and Buteyko Breathing Technique on control pause, dyspnea, pulmonary function, and asthma control in patients with bronchial asthma.This study aims to compare the effects of Alternate Nostril Breathing and Buteyko Breathing Technique on control pause, dyspnea, pulmonary function, and asthma control in patients with bronchial asthma.This study aims to compare the effects of Alternate Nostril Breathing and Buteyko Breathing Technique on control pause, dyspnea, pulmonary function, and asthma control in patients with bronchial asthma.A total of 40 patients with mild to moderate persistent bronchial asthma will be recruited and randomly allocated into two groups. Group A will receive Alternate Nostril Breathing, while Group B will receive the Buteyko Breathing Technique, along with standard pharmacological management. The intervention will be conducted over a period of four weeks, with two supervised sessions per week and additional home-based sessions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Alternative Nostril Breathing Technique along with standard pharmacological management | Patients in this group will receive alternative nostril breathing technique along with standard pharmacological management. A total 4 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Alternative nostril breathing will be performed in sitting position. The patient will be asked to place their right thumb to gently close their right nostril. Inhale slowly for 4 sec deeply through left nostril and hold breath for 2-3 sec. Release right nostril and use your right ring finger to close your left nostril. Exhale slowly 6 sec and completely through right nostril.Inhale slowly 4 sec and deeply through right nostril.Then hold breath for 2-3 sec. Patients will be asked to release the left nostril and use their right thumb to close their right nostril. Exhale slowly and completely through left nostril over 6 sec.Repeat the cycle. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist |
| OTHER | Buteyko breathing along with pharmacological management | Patient in this group will receive Buteyko breathing along with pharmacological management. A total 4 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days will be done by patients at home. The patient will sit comfortably in upright position. The patients will be give following instructions. Breathe normally for 2-3 minutes (nasal inhalation and nasal exhalation). After relax exhale, hold your breath, use index finger and thumb to plug nose. Retain your breath until you feel the urge to breathe (first sign of air hunger) then inhale. Breath normally for 10 sec. Repeat several times. Pharmacological management: Patient will receive medications as prescribed by pulmonologist |
Timeline
- Start date
- 2026-02-28
- Primary completion
- 2026-05-15
- Completion
- 2026-05-15
- First posted
- 2026-04-14
- Last updated
- 2026-04-14
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07529847. Inclusion in this directory is not an endorsement.